Marcela M. Cordero Garcia

Array ( [id] => 7977579 [patent_doc_number] => 08071536 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Mutant DNA polymerases with improved pyrophosphorolysis activated polymerization (PAP) ability' [patent_app_type] => utility [patent_app_number] => 12/324491 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20830 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071536.pdf [firstpage_image] =>[orig_patent_app_number] => 12324491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8177190 [patent_doc_number] => 08178487 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Method for providing glutamine' [patent_app_type] => utility [patent_app_number] => 12/277037 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4304 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178487.pdf [firstpage_image] =>[orig_patent_app_number] => 12277037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575933 [patent_doc_number] => 20090143295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'PEPTIDE-BASED ANTIACNE REAGENTS' [patent_app_type] => utility [patent_app_number] => 12/273778 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12389 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143295.pdf [firstpage_image] =>[orig_patent_app_number] => 12273778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501508 [patent_doc_number] => 20110263511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'TIGHT JUNCTION PROTEIN MODULATORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/743816 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12009 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263511.pdf [firstpage_image] =>[orig_patent_app_number] => 12743816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6268291 [patent_doc_number] => 20100298537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Process for the manufacture of persilylated peptides' [patent_app_type] => utility [patent_app_number] => 12/743323 [patent_app_country] => US [patent_app_date] => 2008-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4180 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298537.pdf [firstpage_image] =>[orig_patent_app_number] => 12743323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501597 [patent_doc_number] => 20090162285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'ANTI-INFLAMMATORY FUSION PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/272670 [patent_app_country] => US [patent_app_date] => 2008-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8670 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162285.pdf [firstpage_image] =>[orig_patent_app_number] => 12272670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546633 [patent_doc_number] => 20090156510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'USE OF NOTCH SIGNALING REGULATORS FOR MODULATING OSTEOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/268268 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 9775 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156510.pdf [firstpage_image] =>[orig_patent_app_number] => 12268268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446092 [patent_doc_number] => 20100279931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Insulin Derivative' [patent_app_type] => utility [patent_app_number] => 12/741964 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39896 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279931.pdf [firstpage_image] =>[orig_patent_app_number] => 12741964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316436 [patent_doc_number] => 20090281034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Microencapsulation and sustained release of biologically active polypeptides' [patent_app_type] => utility [patent_app_number] => 12/289857 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13179 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281034.pdf [firstpage_image] =>[orig_patent_app_number] => 12289857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422497 [patent_doc_number] => 20090148952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Materials and methods for controlling isotope effects during fractionation of analytes' [patent_app_type] => utility [patent_app_number] => 12/290784 [patent_app_country] => US [patent_app_date] => 2008-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 27928 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148952.pdf [firstpage_image] =>[orig_patent_app_number] => 12290784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574043 [patent_doc_number] => 20110269699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 13/124838 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17732 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269699.pdf [firstpage_image] =>[orig_patent_app_number] => 13124838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6002801 [patent_doc_number] => 20110118175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'COMPETITIVE INHIBITORS OF INVARIANT CHAIN EXPRESSION AND/OR ECTOPIC CLIP BINDING' [patent_app_type] => utility [patent_app_number] => 12/739459 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 70841 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118175.pdf [firstpage_image] =>[orig_patent_app_number] => 12739459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932648 [patent_doc_number] => 08492347 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus' [patent_app_type] => utility [patent_app_number] => 12/682759 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12879 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12682759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932648 [patent_doc_number] => 08492347 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus' [patent_app_type] => utility [patent_app_number] => 12/682759 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12879 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12682759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8749457 [patent_doc_number] => 08415290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-09 [patent_title] => 'Self-assembling protein hydrogel with bio-active protein' [patent_app_type] => utility [patent_app_number] => 12/249427 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 6399 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12249427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410659 [patent_doc_number] => 20090124558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING NEURAL ANOXIA AND SPREADING DEPRESSION' [patent_app_type] => utility [patent_app_number] => 12/245427 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11941 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124558.pdf [firstpage_image] =>[orig_patent_app_number] => 12245427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539665 [patent_doc_number] => 20090221470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'USE OF AN ECHINOCANDIN ANTIFUNGAL AGENT IN COMBINATION WITH A GLYCOPEPTIDE ANTIBACTERIAL AGENT' [patent_app_type] => utility [patent_app_number] => 12/243076 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11204 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221470.pdf [firstpage_image] =>[orig_patent_app_number] => 12243076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9233011 [patent_doc_number] => 08598314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-03 [patent_title] => 'Peptide-peptidase-inhibitor conjugates and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 12/680539 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 25 [patent_no_of_words] => 51213 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12680539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7703135 [patent_doc_number] => 08088890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 12/239579 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14195 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088890.pdf [firstpage_image] =>[orig_patent_app_number] => 12239579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701541 [patent_doc_number] => 08394763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'Cyclic undecapeptides and derivatives as multiple sclerosis therapies' [patent_app_type] => utility [patent_app_number] => 12/679778 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 12632 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12679778 [rel_patent_id] =>[rel_patent_doc_number] =>)